Skip to main content
Equibles

Caption Management, LLC

Position in INSM — INSMED Inc

CIK 1706766 OKLAHOMA CITY, OK
Back to INSM Full portfolio

Position in INSM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$25,162,320
+$25,162,320 QoQ
Shares Held
236,000
Ownership
0.108%
of shares outstanding
% of Portfolio
1.00%
of 13F equity value
Holder Rank
#109
of 652 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INSM Over Time

Shares Held

Position Value (USD)

Derivatives in INSM

reported options exposure · as of Jun 30, 2026
CallValue
$67,170,600
CallShares
630,000
PutValue
$78,973,434
PutShares
740,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names. INSM ranks #2 (10.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
This page 		236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in INSM

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $67,170,600 630,000
2026-06-30 $78,973,434 740,700
2026-06-30 $25,162,320 236,000
2026-03-31 $7,064,064 43,200
2026-03-31 $16,401,056 100,300
2025-12-31 $40,934,208 235,200
2025-12-31 $22,625,200 130,000
2025-12-31 $40,760,168 234,200
2025-09-30 $11,664 81
2025-09-30 $46,947,260 326,000
2025-09-30 $54,363,775 377,500
2025-06-30 $28,390,544 282,100
2025-06-30 $21,227,793 210,928
2025-06-30 $33,633,888 334,200
2025-03-31 $3,989,967 52,300
2025-03-31 $11,275,662 147,800
2024-12-31 $24,094,545 348,994
2024-12-31 $29,735,528 430,700
2024-12-31 $25,054,616 362,900
2024-09-30 $6,774,400 92,800
2024-09-30 $31,134,500 426,500
2024-09-30 $7,212,400 98,800
2024-06-30 $79,368,200 1,184,600
2024-06-30 $69,546,000 1,038,000
2024-03-31 $971,254 35,800
2024-03-31 $16,541,161 609,700
2024-03-31 $2,709,961 99,888
2023-12-31 $436,959 14,100
2023-09-30 $10,759,025 426,100
2023-09-30 $2,840,625 112,500
2023-06-30 $1,856,800 88,000
2023-06-30 $2,110,000 100,000
2023-06-30 $6,994,650 331,500
2023-03-31 $1,841,400 108,000
2023-03-31 $1,841,400 108,000
2023-03-31 $226,765 13,300
2022-12-31 $539,460 27,000
2022-09-30 $150,780 7,000
2022-06-30 $295,800 15,000
2022-06-30 $591,600 30,000
2022-06-30 $591,600 30,000
2022-03-31 $705,000 30,000
2022-03-31 $705,000 30,000
2022-03-31 $705,000 30,000
2021-09-30 $963,900 35,000
2021-09-30 $2,478,600 90,000
2021-09-30 $2,478,600 90,000
2021-06-30 $1,707,600 60,000
2021-06-30 $1,707,600 60,000
2020-12-31 $426,112 12,800

Report a Problem

Category
Description
Email (optional, for follow-up)